This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX4CM, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $3,212.70, is a delivery order for the supply of 4,566,174,150 units of CATHFLO ACTIVASE 2 MG VIALS. This contract does not have a set-aside designation, indicating open competition.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the DLA Troop Support Medical program. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely a delivery order against that larger IDC.
Generated 1/22/25, 1:02 AM